Healthia Dirección

Dirección controles de criterios 3/4

El CEO de Healthia's es Wes Coote , nombrado en Apr 2019, tiene una permanencia de 4.67 años. compensación anual total es A$660.60K, compuesta por 60.2% salario y 39.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.42% de las acciones de la empresa, por valor de A$3.58M. La antigüedad media del equipo directivo y de la junta directiva es de 1.4 años y 5.6 años, respectivamente.

Información clave

Wes Coote

Chief Executive Officer (CEO)

AU$660.6k

Compensación total

Porcentaje del salario del CEO	60.2%
Permanencia del CEO	4.7yrs
Participación del CEO	1.4%
Permanencia media de la dirección	1.4yrs
Promedio de permanencia en la Junta Directiva	5.6yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Wes Coote en comparación con los beneficios de Healthia?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jun 30 2023	AU$661k	AU$398k	AU$5m
Mar 31 2023	n/a	n/a	AU$3m
Dec 31 2022	n/a	n/a	AU$781k
Sep 30 2022	n/a	n/a	-AU$1m
Jun 30 2022	AU$516k	AU$345k	-AU$3m
Mar 31 2022	n/a	n/a	-AU$2m
Dec 31 2021	n/a	n/a	AU$161k
Sep 30 2021	n/a	n/a	AU$3m
Jun 30 2021	AU$400k	AU$306k	AU$5m
Mar 31 2021	n/a	n/a	AU$6m
Dec 31 2020	n/a	n/a	AU$7m
Sep 30 2020	n/a	n/a	AU$5m
Jun 30 2020	AU$313k	AU$225k	AU$3m
Mar 31 2020	n/a	n/a	AU$1m
Dec 31 2019	n/a	n/a	AU$271k
Sep 30 2019	n/a	n/a	-AU$483k
Jun 30 2019	AU$226k	AU$176k	-AU$1m

Compensación vs. Mercado: La compensación total de Wes($USD439.40K) está por debajo de la media de empresas de tamaño similar en el mercado Australian ($USD625.62K).

Compensación vs. Ingresos: La compensación de Wes ha sido consistente con los resultados de la empresa en el último año.

CEO

Wes Coote

4.7yrs

Permanencia

AU$660,599

Compensación

Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Wesley Coote	Group MD	4.7yrs	AU$660.60k	1.42% A$ 3.6m
Damien Peters	Group Chief Financial Officer	less than a year	AU$319.83k	sin datos
Darren Stewart	Director of Podiatry & Executive Director	no data	AU$115.34k	6.4% A$ 16.1m
Lisa Roach	Group Chief Partnerships Officer & Executive Director	less than a year	AU$391.84k	0.75% A$ 1.9m
Colin Kangisser	CEO of Eyes & Ears Division and Director	2.7yrs	AU$368.92k	3.66% A$ 9.2m
Roy Walker	Chief Executive Officer of Bodies	less than a year	AU$314.24k	sin datos
Dean Hartley	Chief Technology Officer	1.9yrs	AU$261.49k	2.49% A$ 6.3m
Julia Murfitt	General Counsel & Company Secretary	1.8yrs	sin datos	sin datos
Anthony Ganter	Group Chief Business Development & Strategy Officer	no data	AU$341.32k	0% A$ 0
Kerrie Evans	Group Chief Education & Research Officer	no data	sin datos	sin datos
Aaron Kangisser	Chief Operating Officer of Eyes & Ears Division	less than a year	sin datos	sin datos

1.4yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de HLA no se considera experimentado ( 1.4 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Wesley Coote	Group MD	4.7yrs	AU$660.60k	1.42% A$ 3.6m
Darren Stewart	Director of Podiatry & Executive Director	5.6yrs	AU$115.34k	6.4% A$ 16.1m
Lisa Roach	Group Chief Partnerships Officer & Executive Director	1.7yrs	AU$391.84k	0.75% A$ 1.9m
Colin Kangisser	CEO of Eyes & Ears Division and Director	2.7yrs	AU$368.92k	3.66% A$ 9.2m
Glen Richards	Non-Executive Chairman	5.6yrs	AU$130.00k	5.67% A$ 14.3m
Paul Wilson	Independent Non-Executive Director	5.6yrs	AU$80.00k	2.51% A$ 6.3m
Lisa Dalton	Independent Non-Executive Director	5.6yrs	AU$80.00k	0.034% A$ 85.2k

5.6yrs

Permanencia media

Junta con experiencia: La junta directiva de HLA se considera experimentada (5.6 años de antigüedad promedio).

Healthia Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Healthia Limited Announces Board Changes

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought AU$85k worth of stock

Less than half of directors are independent

Healthia Limited, Annual General Meeting, Nov 23, 2022

Recent updates

Healthia Limited Announces Board Changes

Full year 2023 earnings released: EPS: AU$0.04 (vs AU$0.028 loss in FY 2022)

Pacific Equity Partners made an offer to acquire Healthia Limited from MA Financial Group Limited (ASX:MAF), Wilson Asset Management (International) Pty Ltd. and Regal Partners Limited (ASX:RPL) for an offer per share of AUD 1.8.

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

New major risk - Financial position

Full year 2023 earnings released: EPS: AU$0.046 (vs AU$0.028 loss in FY 2022)

Healthia Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

New minor risk - Market cap size

First half 2023 earnings released: EPS: AU$0.03 (vs AU$0.001 loss in 1H 2022)

Healthia Limited (ASX:HLA) agreed to acquire Kosmac & Clemens Optometrists.

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought AU$85k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of Corio Bay Health Group.

Less than half of directors are independent

Healthia Limited (ASX:HLA) acquired Watsonia Physiotherapy.

Healthia Limited, Annual General Meeting, Nov 23, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Corio Bay Health Group.

Full year 2022 earnings released: AU$0.028 loss per share (vs AU$0.065 profit in FY 2021)

Healthia Limited Determines Not to Declare the Payment of A Final Dividend for 2022

Healthia Limited to Report Fiscal Year 2022 Results on Aug 31, 2022

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Now 22% undervalued after recent price drop

Less than half of directors are independent

Healthia Limited Announces Board Changes

Board Member recently sold AU$52k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Healthia Limited Announces Dividend on HLA - ORDINARY FULLY PAID for the Six Months Ended 31 Dec. 2021, Payable on 24 March 2022

Healthia Limited Recommends Interim Dividend, Payable on March 22, 2022

Healthia Limited to Report First Half, 2022 Results on Feb 28, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Mornington Peninsula Family Physiotherapy.

Board Member recently bought AU$64k worth of stock

Healthia Limited has completed a Follow-on Equity Offering in the amount of AUD 22.268376 million.

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.043 in FY 2020)

Investor sentiment improved over the past week

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire John Holme Optometrist Mareeba.

Healthia Limited (ASX:HLA) agreed to acquire The Eyecare Place for AUD 0.62 million.

Healthia Limited (ASX:HLA) completed the acquisition of Sandringham Sports Physio.

Independent Non-Executive Director recently bought AU$96k worth of stock

Healthia Limited (ASX:HLA) acquired 4 physiotherapy clinics for AUD 1.3 million.

Healthia Limited (ASX:HLA) completed the acquisition of The Physio Clinic for AUD 2 million.

Investor sentiment improved over the past week

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire The Physio Clinic for AUD 2 million.

Healthia Limited (ASX:HLA) completed the acquisition of The Optical Company Pty Ltd from Kangisser Family Trust and Chester Capital Investment Trust.

Healthia Limited (ASX:HLA) entered into an binding agreement to acquire The Optical Company Pty Ltd from Kangisser Family Trust and Chester Capital Investment Trust for AUD 43.8 million.

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire North Queensland Physiotherapy Centre for AUD 1.7 million.

Group COO & Executive Director recently sold AU$197k worth of stock

Non-Executive Chairman recently bought AU$52k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of 4 specialty hand therapy clinics in Sydney.

Healthia Limited (ASX:HLA) entered into agreement to acquire 3 Physiotherapy Clinics in Queensland and 1 Podiatry clinic in South Australia for AUD 5.1 million

Healthia Limited (ASX:HLA) acquired 12 Clinics of The Foot and Ankle Clinic in Melbourne and regional Victoria for AUD 5 million.

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media